Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

MDT / Medtronic plc 8-K (Current Report)

Document (5-0)

Should Value Investors Consider Medtronic (MDT) Stock Now?

2018-03-23 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. (5-0)

Can Boston Scientific's Pain be a Boon for Edwards & Others?

2018-03-22 zacks
The transcatheter aortic valve replacement (TAVR) market, which is projected to witness CAGR of 18.3% between 2017 and 2022 (per a report by Azoth Analytics published on ReportsnReports), has been constantly under the radar of market experts, courtesy of the stir caused by one of the forerunners within this space — Boston Scientific Corporation (BSX - Free Report) . (104-0)

Neovasc taps former Boston Scientific CRM vet Colen for CEO | Personnel Moves January 22, 2018 - MassDevice

2018-03-21 massdevice
Neovasc (NSDQ:NVCN) said today it tapped former Boston Scientific (NYSE:BSX) cardiac rhythm management lead Fred Colen as its new chief executive officer, with former CEO Alexei Marko staying on as an advisor and member of the company’s board of directors. (63-0)

7 High-Quality Dividends for 2018 and Beyond | InvestorPlace

2018-03-21 investorplace
Are you ready to find the holy grail of dividend investing? The ideal dividends are stocks in strong companies which pay out a high dividend yield. Savvy investors can reinvest payments and, over time, create a veritable treasure trove of double-digit annual gains. (112-0)

Medtronic (MDT) Announces Positive Results on AdaptivCRT

2018-03-21 zacks
Medtronic plc (MDT - Free Report) announced positive results from two analyses conducted on AdaptivCRT algorithm at the European Heart Rhythm Association (“EHRA”) Scientific Sessions 2018 in Barcelona, Spain. (45-0)

It Is Still Not Too Late To Pick Up Haemonetics In CY 2018

2018-03-20 seekingalpha
Haemonetics’ plasma franchise is a solid success story waiting to unfold in the next one to two years. (58-0)

Goldman Sachs Backs Emerging Markets: MedTech Stocks in Focus

2018-03-20 zacks
Emerging market investment has taken a backseat of late, thanks to the nonstop blows to the economy. The lingering geopolitical tension in Gulf, debt and policy related hazards in Latin America or the missile tests in North Korea have led stock investors to reconsider their outlay in these markets, earlier proclaimed to offer better growth opportunities than the United States. Going by the MSCI Emerging Markets Index, the last five-year annualized growth rate was just 5. (48-0)

New Analyses Confirm Patients with Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active

2018-03-20 globenewswire
DUBLIN and BARCELONA, Spain - March 20, 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial fibrillation (AF) episodes, as well as tied to higher patient activity levels. The results, involving 408 patients with heart failure and a Medtronic cardiac resynchronization therapy (CRT) device at 26 centers in Italy, were unveiled at the European Heart Rhythm Association (EHRA) Scientific Sessions 2018 in Barcelona, Spain. (5-0)

Nick's Portfolio Tournament First Round Results

2018-03-19 seekingalpha
Alright basketball fans and portfolio managers, here we have it: the first round results of the 2018 Nick's Portfolio Tournament. For those of you who missed it, I said out the selection committee's decision in this introductory piece a week ago. First of all, let me preface this piece by saying that this was a bit of a marathon type-fest, so I ask that you please forgive any typos ahead of time. Secondly, I want to re-hash the competition criteria. (632-0)

J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit

2018-03-19 zacks
Johnson & Johnson (JNJ - Free Report) announced that it has received a binding offer of approximately $2.1 billion from a private equity firm, Platinum Equity, for its LifeScan diabetes device unit. The LifeScan unit makes blood glucose monitoring products and generated revenues of $1.5 billion last year. (95-0)

10 Top Irish Stocks Worth Keeping an Eye On

2018-03-17 247wallst
If the St. Patrick’s Day observances have investors pondering opportunities in the Emerald Isle, there are a few things to know. First, Ireland has been known for some time for its low corporate tax rate, which even prompted some U.S. companies to move their headquarters there. That was often accomplished by means of a so-called tax inversion, in which a merger or acquisition allows the company to claim the headquarters of the Irish (or other foreign) partner as its own. (108-0)

Is the Tax Repeal Only Glitter and No Gold for MedTech?

2018-03-16 zacks
The medical device tax suspension up to Jan 1, 2020, is one of the very few amendments that have garnered the maximum number of bipartisan votes in the House. (35-0)

Retirement Strategies: The Joys Of Changing Careers And A Closer Look At U.S Steel

2018-03-16 seekingalpha
World leaders, as well as Wall Street, appear concerned about President Trump’s plans to 25% tariff on steel imports and 10% on aluminum imports. As a result, Trump is sending Commerce Secretary Wilbur Ross to meet with members of the European Union about these tariffs. U.S. Steel (NYSE:X) might be worse off after tariffs. (72-0)

'Safer' Dividend Aristocrats Gain Best By Walmart, Mickey D, Procter, Leggett And Medtronic, Per March Targets

2018-03-15 seekingalpha
42 of 53 S&P 500 Dividend Aristocrats stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields 3/13/18. (133-0)

CUSIP: G5960L103